financetom
Market
financetom
/
Market
/
Ethos' pre-IPO lock-in ends on Nov 25, stock surges 6% in trade
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ethos' pre-IPO lock-in ends on Nov 25, stock surges 6% in trade
Nov 4, 2022 8:00 AM

Luxury watch retailer Ethos is buzzing after a strong quarter where the company reported its highest-ever EBITDA revenues and profit numbers.

However, the lock-in period for this company is about to end on November 25. Investors must have 59 percent shareholding to escape the lock-in.

Prominent pre-IPO investors are Abakkus Growth Fund with 1.3 percent stake, Alchemy Capital with 2.19 percent stake, and Markertich Consultancy with 1.03 percent stake.

Pulkit Seksharia with 1.17 percent, Siddharth Iyer with 2.11 percent, and Mukul Agrawal with 3.96 percent will be eligible to offload their stakes.

The stock's current market price is Rs 977 versus the IPO issue price of Rs 878.

Speaking to CNBC-TV18, Yashovardhan Saboo, Founder & Chairman of Ethos, said despite global headwinds in business, results are better than expected, and they maintain revenue guidance of 30-35 percent.

In addition, Saboo believes Indian markets remain very strong, and they are seeing a good third quarter ahead.

However, he added there might be some delays in the opening of new stores.

Watch video for more.

Also Watch: Rainbow Children's stock surges 14% with pre-IPO lock-in ending tomorrow

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
XORTX Therapeutics Down Near 10% In US Premarket As Prices US$1.1 Million Registered Direct Offering
XORTX Therapeutics Down Near 10% In US Premarket As Prices US$1.1 Million Registered Direct Offering
Oct 21, 2025
08:13 AM EDT, 10/21/2025 (MT Newswires) -- XORTX Therapeutics ( XRTX ) , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, was down near 10% in US premarket after announcing Tuesday that it has entered into a securities purchase agreement with an institutional investor for the purchase and sale of...
Investors Parse Earnings Reports With US Equity Futures Flat Tuesday Pre-Bell
Investors Parse Earnings Reports With US Equity Futures Flat Tuesday Pre-Bell
Oct 21, 2025
08:09 AM EDT, 10/21/2025 (MT Newswires) -- US stock futures were little changed in Tuesday's premarket session as investors parsed pre-market earning reports and looked ahead to reports coming out later in the day and week. General Motors (GM), Coca-Cola (KO), Lockheed Martin (LMT), and Phillip Morris (PM) all reported earnings beats pre-bell. Dow Jones Industrial Average futures were up...
US STOCKS-Wall Street futures subdued as earnings season gains momentum
US STOCKS-Wall Street futures subdued as earnings season gains momentum
Oct 21, 2025
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.) * Futures flat: Dow up 0.03%, S&P 500 up 0.03%, Nasdaq down 0.02% * Fluor gains after reports Starboard has taken nearly 5% stake * Health insurers rise after upbeat results from Elevance (Updates prices) By Pranav Kashyap and...
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Tuesday as Rate-Cut Bets Offset by Earnings Watch
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Tuesday as Rate-Cut Bets Offset by Earnings Watch
Oct 21, 2025
08:32 AM EDT, 10/21/2025 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust ( SPY ) was up 0.04% and the actively traded Invesco QQQ Trust (QQQ) was 0.02% higher in Tuesday's premarket activity as hopes of an interest rate cut were offset by a focus on corporate earnings. US stock futures were mixed, with S&P...
Copyright 2023-2026 - www.financetom.com All Rights Reserved